For breast cancer, it has been shown that aminopeptidase activity is increased in neoplastic tissue 18 and in a previous study 36.2% of studied breast cancer patients were positive to CD13 which significantly correlated with tumor type, neoangiogenesis and life expectancy.19 This evidence concerns the gene CPQ and breast cancer.